A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes

Abstract

BackgroundPatients presenting with parkinsonian syndromes share many clinical features, which can make diagnosis difficult. This is important as atypical parkinsonian syndromes (APSs) such as progressive supranuclear palsy (PSP), multiple system...